Fortrea Holdings FTRE
NASDAQ FTRE
$18.24 -0.38 (-2.04%)
As of: Sep 4, 2026 · 12:49 PM EDT

Fortrea Holdings (FTRE) EPS (Diluted) (2022 - 2026)

Analysis

Fortrea Holdings (FTRE) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 12.23
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 7.15
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.05 Bn 44.05 Bn - -3.06
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.52 Bn 27.68 Bn - 0.15
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -0.06
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn -0.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Mar 31, 2026 -0.25
Dec 31, 2025 -0.36
Sep 30, 2025 -0.17
Jun 30, 2025 -4.14
Mar 31, 2025 -6.25
Dec 31, 2024 -0.34
Sep 30, 2024 -0.16
Jun 30, 2024 -0.77
Mar 31, 2024 -0.57
Dec 31, 2023 -0.31
Sep 30, 2023 -0.08
Jun 30, 2023 0.17
Mar 31, 2023 0.07
Dec 31, 2022 -0.08
Sep 30, 2022 0.34
Jun 30, 2022 0.37